Sale of Common Stock (Details 2) (USD $)	1 Months Ended		3 Months Ended		9 Months Ended			0 Months Ended	3 Months Ended	7 Months Ended	9 Months Ended		3 Months Ended	7 Months Ended	9 Months Ended		0 Months Ended		3 Months Ended		0 Months Ended			0 Months Ended
	Sep. 30, 2013	Feb. 28, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Sep. 18, 2013 February 2013 Warrants	Sep. 30, 2013 February 2013 Warrants	Sep. 30, 2013 February 2013 Warrants	Sep. 30, 2013 February 2013 Warrants	Feb. 22, 2013 February 2013 Warrants	Sep. 30, 2013 February 2013 SPA Option	Sep. 30, 2013 February 2013 SPA Option	Sep. 30, 2013 February 2013 SPA Option	Feb. 22, 2013 February 2013 SPA Option	Sep. 18, 2013 February 2013 SPA	Feb. 22, 2013 February 2013 SPA	Dec. 31, 2013 February 2013 SPA	Sep. 30, 2013 February 2013 SPA	Feb. 22, 2013 February 2013 SPA February 2013 Warrants	Feb. 22, 2013 February 2013 SPA February 2013 Investor Warrants	Feb. 22, 2013 February 2013 SPA February 2013 Placement Agent Warrants	Feb. 22, 2013 February 2013 SPA February 2013 SPA Option High end of range	Feb. 22, 2013 February 2013 Right to Shares Agreement item	Sep. 30, 2013 February 2013 Right to Shares Agreement
Sale of Common Stock
Shares of common stock sold	125,000,000		125,000,000		125,000,000		32,434,000											26,933,333
Common stock, share price (in dollars per share)																		$ 0.15
Common stock issuable under warrants																						26,933,333	1,885,333
Gross proceeds from sale of common stock	$ 1,750,000	$ 4,040,000																				$ 4,040,000
Net proceeds from sale of common stock																						3,504,000
Term to hold share purchase																		24 months
Number of investors entered into agreement																									1
Common stock, shares unissued	37,538,000		37,538,000		37,538,000																				7,000,000
Rights to purchase common stock (in shares)																									7,000,000
Additional consideration paid upon the issuance of the shares																									0
Period for obligation to deliver shares																									3 days
Common stock, shares reserved but unissued	37,538,000		37,538,000		37,538,000																					19,000,000
Portion of shares of common stock and warrants available for same per share purchase price (as a percent)																								0.5
Additional shares issued																	40,400,001
Number of shares and warrants purchased under the option															0
Warrants
Beginning balance (in shares)										28,818,666				13,466,667
Add: Adjustments for anti-dilution (in shares)								43,228,001		43,228,001
Ending balance (in shares)									72,046,667	72,046,667	72,046,667		13,466,667	13,466,667	13,466,667
Term of warrants																					5 years
Number of shares exercisable under warrants issued																					28,818,666
Exercise price of warrants (in dollars per share)								$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.20	$ 0.15	$ 0.15	$ 0.15	$ 0.15					$ 0.20
Exercise price for adjustments (in dollars per share)										$ 0.08				$ 0.06
Adjusted exercise price of warrants (in dollars per share)										$ 0.08
Period for presenting effective registration statement for avoiding cashless exercise of warrants																					180 days
Limitation of beneficial ownership of common stock for exercise of warrants (as a percent)																					4.99%
Discretionary increase in limitation of beneficial ownership of common stock for exercise of warrants (as a percent)																					9.99%
Notice period for discretionary increase in limitation of beneficial ownership of common stock for exercise of warrants																					61 days
Grant date fair value									2,759,000	2,759,000	2,759,000		1,211,000	1,211,000	1,211,000
Fair value of derivative liability									3,182,000	3,182,000	3,182,000		0	0	0
Impact to other income (expense)			1,078,000	(1,117,000)	3,192,000	(3,517,000)			(1,165,000)		(423,000)		404,000		1,211,000
Proceeds received to be used for investor relations																		1,000,000
Payments made for investor relations																		500,000
Amount released from escrow account to investor relations firm																			$ 250,000	$ 250,000
Amortization period of investor relations payment																		1 year